<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Debnath J</submitter><funding>NIA NIH HHS</funding><funding>The Mark Foundation for Cancer Research</funding><funding>Samuel Waxman Cancer Research Foundation</funding><funding>UCSF QB3 Calico Longevity Fellowship</funding><funding>Government of Canada</funding><funding>NCI NIH HHS</funding><funding>NIH</funding><funding>Cancer Research Society Scholarship for Next Generation of Scientists</funding><pagination>2498-2499</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9542525</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(10)</volume><pubmed_abstract>Both macroautophagy/autophagy and extracellular vesicle (EV) secretion pathways converge upon the endolysosome system. Although lysosome impairment leads to defects in autophagic degradation, the impact of such dysfunction on EV secretion remains poorly understood. Recently, we uncovered a novel secretory autophagy pathway that employs EVs and nanoparticles (EVPs) for the secretion of autophagy cargo receptors outside the cell when either autophagosome maturation or lysosomal function is blocked. We term this process secretory autophagy during lysosome inhibition (SALI). SALI functionally requires multiple steps in classical autophagosome formation and the small GTPase RAB27A. Because the intracellular accumulation of autophagy cargo receptors perturbs cell signaling and quality control pa</pubmed_abstract><journal>Autophagy</journal><pubmed_title>Secretory autophagy during lysosome inhibition (SALI).</pubmed_title><pmcid>PMC9542525</pmcid><funding_grant_id>22805</funding_grant_id><funding_grant_id>R01 CA126792</funding_grant_id><funding_grant_id>R21 CA201849</funding_grant_id><funding_grant_id>R01 AG057462</funding_grant_id><funding_grant_id>R01 CA213775</funding_grant_id><funding_grant_id>CA201849</funding_grant_id><funding_grant_id>201409BPF-335868</funding_grant_id><pubmed_authors>Debnath J</pubmed_authors><pubmed_authors>Leidal AM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Secretory autophagy during lysosome inhibition (SALI).</name><description>Both macroautophagy/autophagy and extracellular vesicle (EV) secretion pathways converge upon the endolysosome system. Although lysosome impairment leads to defects in autophagic degradation, the impact of such dysfunction on EV secretion remains poorly understood. Recently, we uncovered a novel secretory autophagy pathway that employs EVs and nanoparticles (EVPs) for the secretion of autophagy cargo receptors outside the cell when either autophagosome maturation or lysosomal function is blocked. We term this process secretory autophagy during lysosome inhibition (SALI). SALI functionally requires multiple steps in classical autophagosome formation and the small GTPase RAB27A. Because the intracellular accumulation of autophagy cargo receptors perturbs cell signaling and quality control pa</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-22T21:12:22.124Z</modification><creation>2025-04-22T21:12:22.124Z</creation></dates><accession>S-EPMC9542525</accession><cross_references><pubmed>35786367</pubmed><doi>10.1080/15548627.2022.2095788</doi></cross_references></HashMap>